Press Releases

Our latest news and press releases

All 2024 2023 2022 2021 2020

04 Mar 2020
16:05 E.S.T.

Cellectis and Servier Execute the Amendment Confirming the Expansion of their Collaboration on UCART19 Products

25 Feb 2020
16:30 E.S.T.

Cellectis to Hold Fourth Quarter and Full Year 2019 Earnings Call on Thursday, March 5, 2020 at 7:30 AM EST

18 Feb 2020
16:30 E.S.T.

Cellectis and Servier Expand Collaboration on UCART19 Products

15 Jan 2020
16:30 E.S.T.

First Patient Dosed with Cellectis’ New Allogeneic UCART123 Product Candidate for Relapsed/Refractory Acute Myeloid Leukemia

12 Jan 2020
16:00 E.S.T.

Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement

06 Jan 2020
16:30 E.S.T.

An Expert Review on Allogeneic CAR-T for Cancer Published in Nature Reviews Drug Discovery